Clinical trials in Algeria
124 studies list at least one site in Algeria. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-18.
Status
- Completed
- 96
- Recruiting
- 10
- Active, not recruiting
- 7
- Status unknown
- 4
- Not yet recruiting
- 3
- Terminated
- 3
Phase
- Phase 3
- 37
- Phase 4
- 11
- Phase 2
- 8
- Phase 1
- 1
Most studied here
Who runs them
Novo Nordisk A/S (35) · Sanofi (7) · Hoffmann-La Roche (7) · Novartis Pharmaceuticals (6) · AstraZeneca (5) · Bayer (5) · Société Algérienne de Formation et Recherche en Oncologie (3) · Beker Laboratories (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 124 — search for more.
- OBESIAL: A Prospective Interventional Real-world Study of a Multidisciplinary Obesity Management ProgrammeRecruitingNCT07779343Not applicable
- Essential Oils for Urinary Symptoms in Multiple Sclerosis PatientsNot yet recruitingNCT07599189Not applicable
- A Study to Learn About the C1-Inhibitor Function as Diagnosis for Hereditary AngioedemaRecruitingNCT07293364Not applicable
- Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic DiseaseRecruitingNCT07542496
- Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in AlgeriaRecruitingNCT07484971
- Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Gastric Cancers in AlgeriaRecruitingNCT07481110
- Oral and Salivary Biomarkers Associated With StrokeNot yet recruitingNCT07357155
- Pregnancies Before the Diagnosis of Systemic Lupus ErythematosusRecruitingNCT07148115
- ALG-LungCancerRegistry (SAFRO2202)RecruitingNCT07161882
- Efficacy of Neoadjuvant Subcutaneous Trastuzumab-Pertuzumab in Algerian Women With Locally Advanced HER2 Positive Breast CancerRecruitingNCT07166185
- AutoInflammatory Disease Alliance Registry (AIDA)RecruitingNCT05200715
- Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.RecruitingNCT05190094Phase 2
- Impact of Chromium Supplementation on Glucido-lipidic Metabolism, Oxidative Stress and Inflammatory State in Patients with Gestational DiabetesNot yet recruitingNCT06860087Phase 1/2
- A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without InhibitorsActive, not recruitingNCT05135559Phase 3
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without InhibitorsActive, not recruitingNCT04082429Phase 3
- Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia With InhibitorsActive, not recruitingNCT04083781Phase 3
- A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a DayActive, not recruitingNCT03878446Phase 2
- To Describe How Well Vinorelbine Given Orally Works in Patients With a Breast Cancer After 2 Years of TreatmentActive, not recruitingNCT06500494
- Clinical Observation of Renal Function Reactivation Following a GRAS-Based Protocol in Patients With Chronic Kidney Disease and Long-Term Renal Arrest.CompletedNCT07555327
- A Research Study in Children With a Low Level of Hormone to Grow. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day (REAL4)CompletedNCT03811535Phase 3
- Combined Physical Therapy and Hold-Relax Technique for Adolescent Osgood-Schlatter Knee PainCompletedNCT07590128Not applicable
- Confirm Rx Insertable Cardiac Monitor SMART RegistryCompletedNCT03505801
- Acute Metabolic Outcomes in Diabetic Patients Hospitalized for COVID-19 (DMD-COV)CompletedNCT07560059
- Metabolic Regeneration Registry for Periodontal Health (20-Patient Cohort).CompletedNCT07538661
- This Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.CompletedNCT07442110
- Mediterranean Diet and Physical Activity in Breast Cancer Patients Under Hormone TherapyCompletedNCT07443787Not applicable
- Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple SclerosisActive, not recruitingNCT05134441Phase 3
- SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes TrialCompletedNCT04972721
- Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia BCompletedNCT02141074Phase 3
- Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia ACompletedNCT02137850Phase 3
- Floor-Lift Series Pulmonary Rehabilitation for COPD: Short- and Long-Term Outcomes in a North African SettingActive, not recruitingNCT07277855Not applicable
- A Heart Disease Study of Semaglutide in Patients With Type 2 DiabetesCompletedNCT03914326Phase 3
- Observational Study:Safety,Efficacy and Quality of Life of Patients With Atrial Fibrillation, Treated With Trombix®CompletedNCT06184204
- SPATAX: Clinical and Genetic Analysis of Cerebellar Ataxias and Spastic ParaplegiasCompletedNCT00140829
- Safety Study of Rituximab (SC) Administered in Participants With CD20+ DLBCL or CD20+ Follicular NHL Grade 1 to 3ACompletedNCT02406092Phase 3
- A Research Study Comparing a New Medicine Oral Semaglutide to Sitagliptin in People With Type 2 DiabetesCompletedNCT04017832Phase 3
- A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 DiabetesCompletedNCT04109547Phase 3
- Effect of Moringa Oleifera Leaves on Glycemic Control of Women With Type 2 DiabetesCompletedNCT06517602Not applicable
- Factors Influencing Occurrence of Bile Leaks in SurgeryCompletedNCT04665427Not applicable
- Morbidity in Newly Diagnosed type2 Diabetes in AdultsCompletedNCT02002091
- Real-world Clinical Patterns Of Care And Outcomes Among AfME mRCC Patients Receiving Sunitinib as First Line Therapy.TerminatedNCT03140176
- Evaluation of the Efficacy of Respicure® (Resveratrol / Quercetin) in the Management of Respiratory Conditions Including Asthma,COPD and Long COVID.CompletedNCT05601180Not applicable
- Using Speech to Monitor Symptom Severity in Arabic Speaking Patients With SchizophreniaCompletedNCT05563818
- Effectiveness and Safety of Generic Delayed-Release Dimethyl Fumarate (Sclera® or Marovarex ®, Hikma) in Routine Medical Practice in the Treatment of Relapsing-Remitting Multiple Sclerosis in MENA RegionCompletedNCT04468165
- An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase InhibitorsCompletedNCT02303444
- GlucoVIP - Diabetes Treatment by Glucobay® With a Special Therapeutic View to Chosen Patient GroupsCompletedNCT00909051
- High Dose Therapy Followed by Autologous Transplantation for Myeloma Patients With Severe Renal ImpairmentCompletedNCT03234335
- A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) InfectionCompletedNCT02219490Phase 3
- Epidemiology of Breast Cancer in Women Based on Diagnosis Data From Oncologists and Breast Surgeons in AlgeriaCompletedNCT02733601
- Fulvestrant Versus Fulvestrant Plus Palbociclib in Operable Breast Cancer Responding to FulvestrantCompletedNCT03447132Phase 3